跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis
Shiao-Ya Hong
, Ya-Ting Lu
, Shih-Yu Chen
, Chiung-Fang Hsu
, Yi-Chun Lu
, Cheng-Yi Wang
*
, Kun-Lun Huang
*
*
此作品的通信作者
醫學生物技術暨檢驗學系
研究成果
:
Article
›
同行評審
38
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Inflammation
100%
Macrophages
100%
Pulmonary Fibrosis
100%
SHP-1
100%
Agonist Treatment
30%
Myofibroblast Differentiation
23%
CSF1R
23%
Overall Survival
15%
Bleomycin-induced Pulmonary Fibrosis
15%
Fibrosis
7%
Monocyte-derived Macrophages
7%
Collagen Deposition
7%
Transition Marker
7%
Lung
7%
Histological Examination
7%
Lung Function
7%
Dose Effect
7%
FDA-approved Drugs
7%
Lung Inflammation
7%
Bleomycin
7%
Computed Tomography Images
7%
Murine Model
7%
Microcomputed Tomography
7%
Alveolar Macrophages
7%
Bronchoalveolar Lavage Fluid
7%
Druggable Targets
7%
COL3A1
7%
ACTA2
7%
Pharmacological Activation
7%
Fibrotic Markers
7%
Macrophage Polarization
7%
Interleukin-13 (IL-13)
7%
M2 Macrophages
7%
Macrophage Survival
7%
Pulmonary Hemorrhage
7%
Alveolar Space
7%
Idiopathic Pulmonary Fibrosis
7%
Circulating Monocytes
7%
CD200
7%
MRC1
7%
Fate Determination
7%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Lung Fibrosis
100%
Overall Survival
33%
Bleomycin-Induced Pulmonary Fibrosis
33%
Pneumonia
16%
Fibrosis
16%
Bleomycin
16%
Deterioration
16%
Fibrosing Alveolitis
16%
Lung Hemorrhage
16%
Diseases
16%